Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hip implant put to the test: will it stay put?

NCT ID NCT02850575

Knowledge-focused Sponsor: Medacta International SA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking how well a new type of hip implant (the Mpact Double Mobility cup) stays fixed to the bone over the long term. It involves 150 adults between 18 and 80 who are getting their first hip replacement. Researchers will use special imaging and X-rays to measure implant stability and any complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Jan 2014

Expected to finish

Jan 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients eligible for a total hip replacement at the investigational sites will be invited in the study

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * primary hip replacement * patients 18 to 80 years old * patients who accept the follow-up schedule Exclusion Criteria: * femoral neck fracture * patients requiring grafts * progressive local or systemic infections * patients presenting muscular deficiency, neuromuscular disease or vascular insufficiency of the involved limb * patients suffering from diseases that can compromize the recovery to independent mobility * patients with BMI \> 40 * patients with cognitive diseases that can compromize their participation in the study * patients living in geographical area not allowing the clinical follow-up to be performed * patients participating in other biomedical research * patients \<18 years old * patients \> 80 years old * pregnant or breast feeding women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Total hip replacement are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Total hip replacement

Contacts and locations

Locations

  • Clinique Générale

    Annecy, France, 74000, France

  • Orthéo - Espace Fauriel

    Saint-Etienne, France, 42100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.